Photosensitive Biomimetic Nanomedicine‐Mediated Recombination of Adipose Microenvironments for Antiobesity Therapy
Advanced Materials · 2025-07 · 37 (30)
DOI: 10.1002/adma.202417377 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 22.05.2025. Verfasst von Mingming Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Nanjing Drum Tower Hospital, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 211198, Ch…. Hauptthemen laut MEDLINE: Obesity, Biomimetic Materials, Nanomedicine, Anti-Obesity Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Obesity‐induced insulin resistance is a hallmark of metabolic syndrome, and chronic low‐grade inflammation links obesity to insulin resistance through the activation of tissue‐infiltrating immune cells. Current treatments are lacking in efficacy and immunosuppression. Therefore, novel therapies are needed to prevent chronic inflammation and alleviate obesity‐related insulin resistance. In this work, novel red light‐responsive biomimetic nanoparticles (RSCP NPs) are reported to perform targeted delivery of multiple drugs and effectively reduce nonspecific enrichment. These results showed that the dual‐targeting and multiple‐signaling response (red light signaling and different pH microenvironments) of the RSCP NPs enabled the precise delivery of astaxanthin (Asta) and rosiglitazone (Rosi) to M1‐like macrophages and white adipocytes, respectively, to alleviate the low‐grade inflammation of white adipose tissue (WAT) and promote white adipocyte browning. Moreover, RSCP NPs‐mediated Asta and Rosi treatment robustly alleviated insulin resistance and other metabolic disorders in the obese animal models (high‐fat diet (HFD)‐induced or genetically obese mice). Overall, this study provides a theoretical and practical basis for the development and application of novel drug delivery systems for metabolic diseases by elucidating the synergistic long‐term targeting mechanism and target molecule stability of red light‐sensitive bionic nanodrug delivery systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Nanjing Drum Tower Hospital, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 211198, China.
- School of Pharmacy, Anhui Medical University, Hefei, 230032, China.
- State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 211198, China.
- Jiangsu Provincial University Key Laboratory of Drug Discovery for Metabolic Inflammatory Diseases, China Pharmaceutical University, Nanjing, 211198, China.
ORCID-Profile: Chang Liu
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
- Natural Science Foundation of Jiangsu Province
- Natural Science Foundation of Anhui Province
- Natural Science Foundation of Xinjiang Uygur Autonomous Region
- Natural Science Foundation of Chongqing
- Project of State Key Laboratory of Natural Medicines, China Pharmaceutical University
- Priority Academic Program Development of Jiangsu Higher Education Institutions
Zitieren
APA
Song, M., Wang, L., Tian, J., Qin, Y., Zhang, W., Chen, S., & Liu, C. (2025). Photosensitive Biomimetic Nanomedicine‐Mediated Recombination of Adipose Microenvironments for Antiobesity Therapy. Advanced Materials, 37(30). https://doi.org/10.1002/adma.202417377
Vancouver
Song M, Wang L, Tian J, Qin Y, Zhang W, Chen S, et al. Photosensitive Biomimetic Nanomedicine‐Mediated Recombination of Adipose Microenvironments for Antiobesity Therapy. Advanced Materials. 2025;37(30). doi:10.1002/adma.202417377
BibTeX
@article{Song2025,
author = {Song, Mingming and Wang, Li and Tian, Jiameng and Qin, Yadong and Zhang, Wenxiang and Chen, Siyu and Liu, Chang},
title = {Photosensitive Biomimetic Nanomedicine‐Mediated Recombination of Adipose Microenvironments for Antiobesity Therapy},
journal = {Advanced Materials},
year = {2025},
volume = {37},
number = {30},
doi = {10.1002/adma.202417377}
}
EUVIMED